- There are significant macroeconomic challenges
all over the world at the moment:
supply chain challenges, interest rates,
geopolitical challenges, the war in Ukraine,
and so on, so forth; to just name a few.
How do you and how does Exact Sciences build the resilience
as a company to deal with this increasing speed
of disruption?
- First, the way we run our business:
we have to be more disciplined in our investments.
We cannot just have the scattershot approach
in terms of trying to do a thousand things
to eradicate cancer and the suffering that it causes.
We have to be disciplined at what we do,
the time that we spend, the money that we spend,
the priorities that we're going to really focus on.
And that's what we've done at Exact Sciences
over the past year is we know the challenges
that are out there, that money isn't falling off trees,
and we have to make sure that we focus
on those top priorities that are going to really support
our customers in that cancer space.
To do that, we've got to make sure that the money
that we spend has the right return on investment.
As the chief commercial officer,
how do I create leverage?
Either how do I grow our products and I grow them faster,
or how can I really pick and grow more with less?
The second piece around some of the macroeconomic challenges
is the fact that cancer doesn't go away.
We still have to be that company
that's out there supporting our customers,
and we have to do it, I would just say, more productively;
more wisely.
So, how can we provide the same solutions
to our customers, knowing that they're challenged,
because their P&L, their profitability is challenged,
but we can't just simply say, "Well, okay we can't partner
with them."
And I love the way that we provide
very economically smart solutions for cancer care,
and that's what our goal is.
(brief uplifting music)